Category: SPMS-PPMS News

Tcelna – formerly known as Tovaxin – continues research study for SPMS

a Hopeful medication for Secondary MS (SPMS ) Tcelna® (imilecleucel-T) Tcelna® (formerly known as Tovaxin) is a personalized T-cell immunotherapy in a…

Stuart Schlossman

PPMS Study taking place at DUKE UNIVERSITY in North Carolina – ‘RECLASSIFYING MULTIPLE SCLEROSIS’

ABOUT the Study: Brief History and Description The MURDOCK Study – Measurement to Understand the Reclassification of Disease Of Cabarrus /…

Stuart Schlossman